[15883] in Public-Access_Computer_Systems_Forum

home help back first fref pref prev next nref lref last post

Merrill cant buy enough

daemon@ATHENA.MIT.EDU (Faith Foley)
Thu Jun 23 06:20:36 2005

Message-ID: <007c01c577dd$2f24b620$ca5d619f@OHSHN>
From: "Faith Foley" <tomakap@att.net>
To: <pacs@mit.edu>
Date: Thu, 23 Jun 2005 05:51:32 -0600
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0079_01C577B3.464EAE20"

This is a multi-part message in MIME format.

------=_NextPart_000_0079_01C577B3.464EAE20
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

 
&nbsp;
&nbsp;

  
  
    
      
        
        
          
            EMERGING =3D
GROWTH 
            ALERT
        
          Issue: =3D
1025534
          
            June =3D
2005
        
          
            
            
            
              
              
                
                  
                    
                    
                      Pingchuan Pharmaceutical =3D
Inc 
                        Undervalued 
                        Special Situation
                    
                      Symbol: =3D

                      PGCN
                    
                      52 Week Range
                      0.15 - 4.00
                    
                      Shares Float: 
                      25,000,000
                    
                      Current Price:
                      $4.75&nbsp;
                    
                      12 Mo.Target Price
                      $26.00
                    
                      &nbsp;Last 5 days =3D
gain
                      $3.40
            Breaking News 
            Alerts!
            Big News 
            Expected&nbsp;&nbsp;Thursday&nbsp; 
            Jun&nbsp;&nbsp;22&nbsp;Value =3D
should 
            climb quickly!&nbsp; Be ready for the ride of your =3D
life, as 
            you can see so far&nbsp;
            PR Newswire (Tue, Jun 14)Pingchuan Signs =3D
Regional 
            Distribution Contract With Beijing Pingchuan Tianzhi Medical 
            Technology Development Center EDGAR Online (Mon, =3D
May 
            23)PINGCHUAN PHARMACEUTICAL =3D
INC Files 
            SEC form 10QSB, Quarterly Report
            CORPORATE 
            PROFILE :&nbsp;Pingchuan 
            Pharmaceutical Inc. (''PGCN'') is a modernized pharmaceutical 
            manufacturer with first-class medical R&amp;D ability, =3D
pioneered 
            medicine products, and well-established marketing network. =3D
Since its 
            establishment, PGCN has focused its businesses on diabetes =3D
medicine 
            and its medical products. The products of PGCN include health =
=3D
care 
            products, varieties of medicine, as well as medical apparatus. =
=3D
Kang 
            Da Glycosuria Capsule is a successful product of PGCN for =3D
treating 
            diabetes, which was first developed in 1998 and introduced to =
=3D
the 
            market in 2001. PGCN has well-established marketing network =
=3D
and sale 
            branches, which include about 180,000 retail =3D
pharmacies/drugstores 
            across China, agency network in major cities like Beijing, =3D
Shanghai, 
            Guangzhou, and Xi'an, special counter sale at drug chain =3D
stores in 
            key regions, residence community clinic sale and promotion, as =
=3D
well 
            as internet marketing through the company's website. The =3D
marketing 
            network of PGCN covers more than 50% districts of China and =
=3D
exports 
            to US, Japan, Russia, and south-eastern Asia.About =3D
Beijing 
            Pingchuan Tianzhi Medical Technology Development 
            CenterBeijing Pingchuan Tianzhi Medical Technology 
            Development is grouped under Harbin Pingchuan Pharmaceutical =
=3D
Co., 
            Ltd. in Jan. 2000. It is a wholly-owned subsidiary of Harbin 
            Pingchuan Pharmaceutical Company. TIANZHI focuses on dealing =
=3D
with 
            self-produced products, as well as dealing &amp; distributing =
=3D
other 
            medicines, health cares, pharmaceutical apparatuses and 
            international trade businesses TIANZHI was authorized as the 
            exclusive agent for the product of Kangda'an sugar capsule in 
            Beijing area. By the end of 2004, TIANZHI printed out its good =
=3D

            result that the total number of medicine bottles sold out was =
=3D
26,000 
            and the sales revenue in 2004 was 
            RMB400,000.PGCN =3D
is 
            getting ready to break out. We recommend this as a VERY strong =
=3D

            buy.
            
        
          
            &nbsp;
  
    
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      &nbsp;
      grenade  and the US military  was called in When  =3D
the American troops
were  on the scene  a  suicide bomber boarded a  bus of pilgrims
and  detonated himself The attack  killed a US soldier  three policemen =
=3D
and a  civilian Twentytwo civilians were  woundedPolice said that in  =3D
alWaziriya in northern Baghdad  three people launched suicide  attacks One =
=3D
detonated
      woundedPolice said =3D
that
          
------=_NextPart_000_0079_01C577B3.464EAE20
Content-Type: text/html;;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<HTML><HEAD>
<META http-equiv=3DContent-Type content=3Dtext/html;charset=3Diso-8859-1>
<STYLE>yfnc_modtitlew1 {
	WIDTH: 100%
}
yfncsumdatagrid {
	BACKGROUND: #dcdcdc; WIDTH: 100%
}
TD {
	FONT-SIZE: 79%; FONT-FAMILY: arial,helvetica,sans-serif
}
TD {
	LINE-HEIGHT: 1.25em
}
#yfncsubtit {
	WIDTH: 100%
}
ygtb {
	FONT-SIZE: 18px
}
</STYLE>

<META content=3D"MSHTML 6.00.2900.2668" name=3DGENERATOR></HEAD>
<BODY>
<DIV><FONT face=3DTahoma size=3D2><BR><BR></FONT>&nbsp;</DIV>
<DIV><FONT face=3DTahoma size=3D2><BR></FONT>&nbsp;</DIV>
<TABLE borderColor=3D#000000 cellSpacing=3D0 cellPadding=3D0 width=3D654 =
align=3Dcenter 
border=3D1>
  <TBODY>
  <TR>
    <TD width=3D650>
      <TABLE cellSpacing=3D0 cellPadding=3D3 width=3D650 align=3Dcenter =
border=3D0>
        <TBODY>
        <TR bgColor=3D#003399>
          <TD 
          style=3D"PADDING-RIGHT: 8px; PADDING-LEFT: 8px; PADDING-BOTTOM: =
8px; PADDING-TOP: 8px" 
          bgColor=3D#008080 colSpan=3D2 height=3D46>
            <P><FONT size=3D4><STRONG><FONT color=3D#ffffff>EMERGING =
GROWTH 
            ALERT</FONT></STRONG></P></FONT></TD></TR>
        <TR>
          <TD 
          style=3D"PADDING-RIGHT: 2px; PADDING-LEFT: 2px; PADDING-BOTTOM: =
2px; PADDING-TOP: 2px" 
          bgColor=3D#000000><FONT color=3D#ffffff>Issue: =
1025534</FONT></TD>
          <TD 
          style=3D"PADDING-RIGHT: 2px; PADDING-LEFT: 2px; PADDING-BOTTOM: =
2px; PADDING-TOP: 2px" 
          bgColor=3D#000000>
            <DIV align=3Dright><FONT color=3D#ffffff>June =
2005</FONT></DIV></TD></TR>
        <TR>
          <TD 
          style=3D"PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
PADDING-BOTTOM: 10px; PADDING-TOP: 10px" 
          colSpan=3D2>
            <DIV align=3Dleft></DIV>
            <DIV align=3Dleft></DIV>
            <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D325 =
align=3Dright border=3D1>
              <TBODY>
              <TR>
                <TD>
                  <TABLE cellSpacing=3D0 cellPadding=3D3 width=3D325 =
align=3Dright 
                  border=3D1>
                    <TBODY>
                    <TR bgColor=3D#003399>
                      <TD bgColor=3D#008080 colSpan=3D2><B><FONT 
                        color=3D#ffffff>Pingchuan Pharmaceutical =
Inc</FONT> 
                        </B><FONT color=3D#ffffff =
size=3D2><STRONG><BR>Undervalued 
                        Special Situation</STRONG></FONT></TD></TR>
                    <TR>
                      <TD width=3D"53%"><FONT size=3D2>Sy<B></B>mbol: =
</FONT></TD>
                      <TD width=3D"47%"><B><EM><FONT 
                      size=3D2>PGCN</FONT></B></EM></TD></TR>
                    <TR>
                      <TD><FONT size=3D2>52 Week Range</FONT></TD>
                      <TD>0.15 - 4.00</TD></TR>
                    <TR>
                      <TD><FONT size=3D2>Sha<B></B>res Float: </FONT></TD>
                      <TD><FONT size=3D2>25,000,000</FONT></TD></TR>
                    <TR>
                      <TD><FONT size=3D2>Current Price:</FONT></TD>
                      <TD><FONT color=3D#0000ff size=3D2><SPAN 
                        =
class=3D468170001-22062005>$4.75&nbsp;</SPAN></FONT></TD></TR>
                    <TR>
                      <TD><FONT size=3D2>12 Mo.Target Price</FONT></TD>
                      <TD><FONT size=3D2>$26.00</FONT></TD></TR>
                    <TR>
                      <TD><FONT size=3D2>&nbsp;Last 5 days =
gain</FONT></TD>
                      <TD>$3.<SPAN class=3D468170001-22062005><FONT 
                        color=3D#0000ff 
                =
size=3D2>40</FONT></SPAN></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABL=
E>
            <P><EM><FONT color=3D#cc0000 size=3D4><STRONG>Breaking News 
            Alerts!</STRONG></FONT></EM></P>
            <P><FONT color=3D#cc0000 size=3D3><STRONG><EM>Big News 
            Expected&nbsp;</EM></STRONG><SPAN =
class=3D468170001-22062005><FONT 
            color=3D#0000ff =
size=3D2>&nbsp;Thursday&nbsp;</FONT></SPAN><STRONG><EM> 
            Jun&nbsp;</EM></STRONG><SPAN><FONT color=3D#0000ff 
            size=3D2>&nbsp;22&nbsp;</FONT></SPAN><BR><STRONG><EM>Value =
should 
            climb quickly!</EM></STRONG><SPAN =
class=3D468170001-22062005><FONT 
            color=3D#0000ff size=3D2>&nbsp; Be ready for the ride of your =
life, as 
            you can see so far&nbsp;</FONT></SPAN></FONT></P>
            <P><EM><B>PR Newswire (Tue, Jun 14)</B><BR>Pingchuan Signs =
Regional 
            Distribution Contract With Beijing Pingchuan Tianzhi Medical 
            Technology Development Center <BR><BR><B>EDGAR Online (Mon, =
May 
            23)</B></EM><FONT size=3D2><BR><EM>PINGCHUAN PHARMACEUTICAL =
INC Files 
            SEC form 10QSB, Quarterly Report</EM></FONT></P>
            <P><EM><STRONG><FONT color=3D#003399><U>CORPORATE 
            PROFILE</U></FONT></STRONG> <U><FONT color=3D#003399 
            size=3D2>:</FONT></U></EM><FONT =
size=3D2><BR><EM>&nbsp;Pingchuan 
            Pharmaceutical Inc. (''PGCN'') is a modernized pharmaceutical 
            manufacturer with first-class medical R&amp;D ability, =
pioneered 
            medicine products, and well-established marketing network. =
Since its 
            establishment, PGCN has focused its businesses on diabetes =
medicine 
            and its medical products. The products of PGCN include health =
care 
            products, varieties of medicine, as well as medical apparatus. =
Kang 
            Da Glycosuria Capsule is a successful product of PGCN for =
treating 
            diabetes, which was first developed in 1998 and introduced to =
the 
            market in 2001. PGCN has well-established marketing network =
and sale 
            branches, which include about 180,000 retail =
pharmacies/drugstores 
            across China, agency network in major cities like Beijing, =
Shanghai, 
            Guangzhou, and Xi'an, special counter sale at drug chain =
stores in 
            key regions, residence community clinic sale and promotion, as =
well 
            as internet marketing through the company's website. The =
marketing 
            network of PGCN covers more than 50% districts of China and =
exports 
            to US, Japan, Russia, and south-eastern Asia.<BR><BR>About =
Beijing 
            Pingchuan Tianzhi Medical Technology Development 
            Center<BR><BR>Beijing Pingchuan Tianzhi Medical Technology 
            Development is grouped under Harbin Pingchuan Pharmaceutical =
Co., 
            Ltd. in Jan. 2000. It is a wholly-owned subsidiary of Harbin 
            Pingchuan Pharmaceutical Company. TIANZHI focuses on dealing =
with 
            self-produced products, as well as dealing &amp; distributing =
other 
            medicines, health cares, pharmaceutical apparatuses and 
            international trade businesses TIANZHI was authorized as the 
            exclusive agent for the product of Kangda'an sugar capsule in 
            Beijing area. By the end of 2004, TIANZHI printed out its good =

            result that the total number of medicine bottles sold out was =
26,000 
            and the sales revenue in 2004 was 
            RMB400,000.<BR><BR><BR></EM></FONT><B><FONT size=3D2><EM>PGCN =
is 
            getting ready to break out. We recommend this as a VERY strong =

            buy.</EM></FONT></B></P>
            <OL></OL></TD></TR>
        <TR>
          <TD 
          style=3D"PADDING-RIGHT: 15px; PADDING-LEFT: 15px; =
PADDING-BOTTOM: 15px; PADDING-TOP: 15px" 
          colSpan=3D2>
            <P =
align=3Djustify>&nbsp;</P></TD></TR></TBODY></TABLE></TD></TR>
  <TR>
    <TD 
    style=3D"PADDING-RIGHT: 15px; PADDING-LEFT: 15px; PADDING-BOTTOM: =
15px; PADDING-TOP: 15px" 
    colSpan=3D2 height=3D106>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>&nbsp;</P>
      <P align=3Djustify>grenade  and the US military  was called in When  =
the American troops
were  on the scene  a  suicide bomber boarded a  bus of pilgrims
and  detonated himself The attack  killed a US soldier  three policemen =
and a  civilian Twentytwo civilians were  woundedPolice said that in  =
alWaziriya in northern Baghdad  three people launched suicide  attacks One =
detonated
      woundedPolice said =
that</P></TD></TR></TBODY></TABLE><BR></BODY></HTML>

------=_NextPart_000_0079_01C577B3.464EAE20--

home help back first fref pref prev next nref lref last post